Tight junction modulation by chitosan nanoparticles: Comparison with chitosan solution

Agu, 2004, Intranasal delivery of recombinant human parathyroid hormone [hPTH(1-34)], teriparatide in rats, Endocr. Res., 30, 455, 10.1081/ERC-200035957 Artursson, 1994, Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2), Pharm. Res., 11, 1358, 10.1023/A:1018967116988 Behrens, 2002, Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport, Pharm. Res., 19, 1185, 10.1023/A:1019854327540 Bravo-Osuna, 2007, In vitro evaluation of calcium binding capacity of chitosan and thiolated chitosan poly(isobutyl cyanoacrylate) core–shell nanoparticles, Int. J. Pharm., 338, 284, 10.1016/j.ijpharm.2007.01.039 Bravo-Osuna, 2008, Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles, Eur. J. Pharm. Biopharm., 69, 436, 10.1016/j.ejpb.2007.12.012 Calvo, 1997, Novel hydrophylic chitosan-polyethylene oxide nanoparticles as protein carriers, J. Appl. Polym. Sci., 63, 125, 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4 Chemuturi, 2005, Comparison of human tracheal/bronchial epithelial cell culture and bovine nasal respiratory explants for nasal drug transport studies, J. Pharm. Sci., 94, 1976, 10.1002/jps.20404 Colonna, 2008, Ex vivo evaluation of prolidase loaded chitosan nanoparticles for the enzyme replacement therapy, Eur. J. Pharm. Biopharm., 70, 58, 10.1016/j.ejpb.2008.04.014 Dornish, 1996, Alginate and chitosan: Biodegradable biopolymers in drug delivery systems, Eur. J. Pharm. Sci., 4, S153, 10.1016/S0928-0987(97)86467-6 Dyer, 2002, Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles, Pharm. Res., 19, 998, 10.1023/A:1016418523014 Fernandez-Urrusuno, 1999, Enhancement of nasal absorption of insulin using chitosan nanoparticles, Pharm. Res., 16, 1576, 10.1023/A:1018908705446 Florea, 2002, Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and non differentiated COS-1 cell cultures, AAPS Pharm. Sci., 4, E12, 10.1208/ps040312 Florea, 2006, Enhancement of bronchial octreotide absorption by chitosan and N-trimethyl chitosan shows linear in vitro/in vivo correlation, J. Control Release, 110, 353, 10.1016/j.jconrel.2005.10.001 Fiebrig, 1994, Sedimentation analysis of potential interaction between mucins and a putative bioadhesive polymer, Progr. Colloid Polym. Sci., 94, 66, 10.1007/BFb0115603 Grenha, 2007, Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro, Eur. J. Pharm. Sci., 31, 73, 10.1016/j.ejps.2007.02.008 Hirano, 1990, Chitosan: a biocompatible material for oral and intravenous administration Huang, 2004, Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation, Pharm. Res., 21, 344, 10.1023/B:PHAM.0000016249.52831.a5 Huang, 2005, Pulmonary inflammation caused by chitosan microparticles, J. Biomed. Mater. Res. A, 75, 283, 10.1002/jbm.a.30421 Illum, 1998, Chitosan and its use as a pharmaceutical excipient, Pharm. Res., 15, 1326, 10.1023/A:1011929016601 Illum, 2000, Transport of drugs from the nasal cavity to the central nervous system, Eur. J. Pharm. Sci., 11, 1, 10.1016/S0928-0987(00)00087-7 Illum, 2003, Nasal drug delivery--possibilities, problems and solutions, J. Control. Release., 87, 187, 10.1016/S0168-3659(02)00363-2 Illum, 2007, Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?, J. Pharm. Sci., 96, 473, 10.1002/jps.20718 Jung, 2000, Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?, Eur. J. Pharm. Biopharm., 50, 147, 10.1016/S0939-6411(00)00084-9 Katas, 2006, Development and characterization of chitosan nanoparticles for siRNA delivery, J. Control Release, 115, 216, 10.1016/j.jconrel.2006.07.021 Li, 2006, Carbopol-mediated paracellular transport enhancement in Calu-3 cell layers, J. Pharm. Sci., 95, 326, 10.1002/jps.20541 Ma, 2000, Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskeletal involvement, Microsc. Res. Tech., 51, 156, 10.1002/1097-0029(20001015)51:2<156::AID-JEMT7>3.0.CO;2-J Ma, 2003, Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles, Pharm. Res., 20, 1812, 10.1023/B:PHAM.0000003379.76417.3e Mao, 2005, Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells, Pharm. Res., 22, 2058, 10.1007/s11095-005-8175-y Muzzarelli, 1998, Colorimetric determination of chitosan, Anal. Biochem., 260, 255, 10.1006/abio.1998.2705 Prego, 2005, Transmucosal macromolecular drug delivery, J. Control. Release., 101, 151, 10.1016/j.jconrel.2004.07.030 Rabito, 1978, Amiloride and calcium effect on the outer barrier of the frog skin, J. Membr. Biol., 42, 169, 10.1007/BF01885369 Sadeghi, 2008, Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells, Eur. J. Pharm. Biopharm., 70, 270, 10.1016/j.ejpb.2008.03.004 Sayin, 2008, Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery, Int. J. Pharm., 363, 139, 10.1016/j.ijpharm.2008.06.029 Schipper, 1997, Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement, Pharm. Res., 14, 923, 10.1023/A:1012160102740 Schipper, 1996, Chitosans as absorption enhancers for poorly absorbable drugs.1:Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells, Pharm. Res., 13, 1686, 10.1023/A:1016444808000 Seki, 2007, Effects of asperminated gelatin on the nasal absorption of insulin, Int. J. Pharm., 338, 213, 10.1016/j.ijpharm.2007.02.004 Silva, 2006, Effect of chitosan-coated alginate microspheres on the permeability of Caco-2 cell monolayers, Drug. Dev. Ind. Pharm., 32, 1079, 10.1080/03639040600735020 Smith, 2005, Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption, Biomaterials, 26, 3269, 10.1016/j.biomaterials.2004.06.020 Soane, 1999, Evaluation of the clearance characteristics of bioadhesive systems in humans, Int. J. Pharm., 178, 55, 10.1016/S0378-5173(98)00367-6 Stolnik, 2009, Formulations for delivery of therapeutic proteins, Biotechnol. Lett., 31, 1, 10.1007/s10529-008-9834-y Teijeiro-Osorio, 2009, Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro, Eur. J. Pharm. Biopharm., 71, 257, 10.1016/j.ejpb.2008.09.020 Teijeiro-Osorio, 2009, New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules, Biomacromolecules, 10, 243, 10.1021/bm800975j Vila, 2002, Design of biodegradable particles for protein delivery, J. Control Release, 78, 15, 10.1016/S0168-3659(01)00486-2 Vllasaliu, 2008 Witschi, 1999, In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery, Pharm. Res., 16, 382, 10.1023/A:1018869601502 Yang, 2004, Cyclodextrins in nasal delivery of low-molecular-weight heparins: in vivo and in vitro studies, Pharm. Res., 21, 1127, 10.1023/B:PHAM.0000032998.84488.7a